# Lead4Life PPP Call — Lead-212 Radiopharmaceuticals

**Funder:** KWF
**Budget:** €500k–€2M per project; total €5M
**Deadline:** 5 May 2026 (Call opens 5 May 2026; submission deadline not yet specified)
**Consortium:** Required — public-private partnership (PPP) collaboration required
**Application:** Single stage (open competitive selection via KWF GMS)
**Frequency:** One-off
**Eligible countries:** NL
**Official call:** https://www.kwf.nl/en/forresearchers/funding/lead4life
**Last verified:** 27 April 2026

## Eligibility & scope

PPP call for projects strengthening Pb-212 production/supply chain or enabling technologies for clinical application of Pb-212-based radiopharmaceuticals. Proposals must involve public-private collaboration and be submitted through KWF GMS; projects are embedded in a national TRT innovation network. Clinical trials and full therapeutic product development are out of scope.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-lead4life-ppp-call-lead-212-radiopharmaceuticals-2026-05) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.